^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    upifitamab rilsodotin (XMT-1536)

    i
    Other names: XMT-1536, XMT 1536, UpRi, RebmAb200
    Company:
    Recepta, Servier
    Drug class:
    Microtubule inhibitor, NaPi2b-targeted antibody-drug conjugate
    Related drugs:
    Apply
    First-in-Human Study of XMT-1536 in Cancers Likely to Express NaPi2b (Uplift) (NCT03319628)
    Phase 1/2
    Mersana Therapeutics
    Active, not recruiting
    Last update posted :
    11/10/2023
    Initiation :
    12/12/2017
    Primary completion :
    05/31/2023
    Completion :
    10/31/2024
    SLC34A2
    |
    SLC34A2 expression
    |
    cisplatin • upifitamab rilsodotin (XMT-1536)